AGM Outcome with Scrutinizer Report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemo Pharma Laboratories Ltd held its 83rd AGM on September 24, 2025, via video conferencing, where all 11 resolutions were passed with overwhelming shareholder approval of 99.997% in favour (473,059 votes against just 14 votes against). The 8 ordinary resolutions covered adoption of FY25 audited financials, appointment/regularization of directors (Ruchit Mehta as MD & CEO, Utsav Trivedi as Executive Director & CFO, and three Independent Directors), and appointment of secretarial and statutory auditors — with SSRV & Associates replacing the resigned Sanjay Rane & Associates LLP as statutory auditor. The 3 special resolutions are more material: changing the company name to 'Star Source Multi Trade Limited', altering the Object Clause of the Memorandum of Association, and reclassifying Shanta Somani from the promoter group to public shareholder category. Voting turnout was 31.54% of the 15 lakh total shares outstanding.
The name change to 'Star Source Multi Trade' combined with an altered object clause strongly signals a pivot away from the pharma business into multi-trade/commerce activities, which existing shareholders should monitor closely. The reclassification of a promoter group member to public and the auditor change are routine but worth noting. With near-unanimous approval, there is no governance friction for shareholders to worry about from this meeting.